EE200100363A - ((Aminoiminometüül)amino)alkaankarboksamiidid ja nende kasutamine ravis - Google Patents
((Aminoiminometüül)amino)alkaankarboksamiidid ja nende kasutamine ravisInfo
- Publication number
- EE200100363A EE200100363A EEP200100363A EEP200100363A EE200100363A EE 200100363 A EE200100363 A EE 200100363A EE P200100363 A EEP200100363 A EE P200100363A EE P200100363 A EEP200100363 A EE P200100363A EE 200100363 A EE200100363 A EE 200100363A
- Authority
- EE
- Estonia
- Prior art keywords
- alkanecarboxamides
- aminoiminomethyl
- therapy
- amino
- Prior art date
Links
- -1 (Aminoiminomethyl) amino Chemical group 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9900194A FR2788275B1 (fr) | 1999-01-11 | 1999-01-11 | ((aminoiminomethyl)amino) alcane carboxamides et leurs applications en therapeutique |
| PCT/EP1999/010468 WO2000042001A1 (en) | 1999-01-11 | 1999-12-30 | ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100363A true EE200100363A (et) | 2002-10-15 |
Family
ID=9540749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100363A EE200100363A (et) | 1999-01-11 | 1999-12-30 | ((Aminoiminometüül)amino)alkaankarboksamiidid ja nende kasutamine ravis |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6518458B1 (et) |
| EP (1) | EP1140803B1 (et) |
| JP (1) | JP4567889B2 (et) |
| KR (1) | KR100630291B1 (et) |
| CN (1) | CN1182109C (et) |
| AR (1) | AR022221A1 (et) |
| AT (1) | ATE252553T1 (et) |
| AU (1) | AU760147B2 (et) |
| BR (1) | BR9916858A (et) |
| CA (1) | CA2359454C (et) |
| CZ (1) | CZ20012482A3 (et) |
| DE (1) | DE69912315T2 (et) |
| DK (1) | DK1140803T3 (et) |
| EE (1) | EE200100363A (et) |
| ES (1) | ES2207325T3 (et) |
| FR (1) | FR2788275B1 (et) |
| HK (1) | HK1041689B (et) |
| HU (1) | HUP0200023A3 (et) |
| ID (1) | ID29586A (et) |
| IL (1) | IL144225A0 (et) |
| NO (1) | NO20013420D0 (et) |
| NZ (1) | NZ513467A (et) |
| PT (1) | PT1140803E (et) |
| RU (1) | RU2236401C2 (et) |
| SK (1) | SK285130B6 (et) |
| WO (1) | WO2000042001A1 (et) |
| ZA (1) | ZA200106606B (et) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1771206T3 (en) * | 2004-05-05 | 2018-05-22 | Silence Therapeutics Gmbh | LIPIDS, LIPID COMPLEXES AND USE THEREOF |
| BRPI0519468A2 (pt) | 2004-12-27 | 2009-01-27 | Silence Therapeutics Ag | complexos de lipÍdeos revestido e seu uso |
| TW200808705A (en) * | 2006-06-15 | 2008-02-16 | Sanofi Aventis | Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| BRPI0714875A2 (pt) * | 2006-07-21 | 2013-05-28 | Silence Therapeutics Ag | meios para inibir a expressço da proteÍna cinase 3 |
| WO2010074591A1 (ru) * | 2008-12-24 | 2010-07-01 | Закрытое Акционерное Общество "Beptekc" | Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1153424A (en) * | 1965-04-15 | 1969-05-29 | Horlicks Ltd | Pharmaceutical Compositions |
| US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
| JPH0841008A (ja) * | 1994-07-29 | 1996-02-13 | Ono Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害剤 |
| CA2217550A1 (en) * | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
| RU2125458C1 (ru) * | 1997-04-02 | 1999-01-27 | Санкт-Петербургская Государственная Химико-Фармацевтическая Академия | Способ получения комплекса, обладающего адаптогенным, гипогликемическим, антигипоксическим и противовоспалительным действием |
| US6395713B1 (en) * | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
| DE19748697A1 (de) * | 1997-11-04 | 1999-05-06 | Basf Ag | Verfahren zur Herstellung von substituierten Guanidinderivaten |
-
1999
- 1999-01-11 FR FR9900194A patent/FR2788275B1/fr not_active Expired - Fee Related
- 1999-12-30 DE DE69912315T patent/DE69912315T2/de not_active Expired - Lifetime
- 1999-12-30 ES ES99964687T patent/ES2207325T3/es not_active Expired - Lifetime
- 1999-12-30 JP JP2000593569A patent/JP4567889B2/ja not_active Expired - Fee Related
- 1999-12-30 SK SK984-2001A patent/SK285130B6/sk not_active IP Right Cessation
- 1999-12-30 AT AT99964687T patent/ATE252553T1/de not_active IP Right Cessation
- 1999-12-30 NZ NZ513467A patent/NZ513467A/en unknown
- 1999-12-30 IL IL14422599A patent/IL144225A0/xx unknown
- 1999-12-30 KR KR1020017008794A patent/KR100630291B1/ko not_active Expired - Fee Related
- 1999-12-30 PT PT99964687T patent/PT1140803E/pt unknown
- 1999-12-30 EP EP99964687A patent/EP1140803B1/en not_active Expired - Lifetime
- 1999-12-30 DK DK99964687T patent/DK1140803T3/da active
- 1999-12-30 ID IDW00200101657A patent/ID29586A/id unknown
- 1999-12-30 HU HU0200023A patent/HUP0200023A3/hu unknown
- 1999-12-30 AU AU30443/00A patent/AU760147B2/en not_active Ceased
- 1999-12-30 HK HK02103446.2A patent/HK1041689B/zh not_active IP Right Cessation
- 1999-12-30 BR BR9916858-8A patent/BR9916858A/pt not_active Application Discontinuation
- 1999-12-30 US US09/869,957 patent/US6518458B1/en not_active Expired - Lifetime
- 1999-12-30 CZ CZ20012482A patent/CZ20012482A3/cs unknown
- 1999-12-30 WO PCT/EP1999/010468 patent/WO2000042001A1/en not_active Ceased
- 1999-12-30 CN CNB998155640A patent/CN1182109C/zh not_active Expired - Fee Related
- 1999-12-30 EE EEP200100363A patent/EE200100363A/et unknown
- 1999-12-30 CA CA002359454A patent/CA2359454C/en not_active Expired - Fee Related
- 1999-12-30 RU RU2001121195/04A patent/RU2236401C2/ru not_active IP Right Cessation
-
2000
- 2000-01-07 AR ARP000100063A patent/AR022221A1/es unknown
-
2001
- 2001-07-10 NO NO20013420A patent/NO20013420D0/no not_active Application Discontinuation
- 2001-08-10 ZA ZA200106606A patent/ZA200106606B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL156565A0 (en) | N-(phenylsulphonyl) glycine derivatives and their therapeutic use | |
| NO20014560D0 (no) | Quinasoliner og terapautisk anvendelse derav | |
| NO992373D0 (no) | Forlenget anestesi i ledd og kroppshulrom | |
| DK1354888T3 (da) | Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter | |
| IS6411A (is) | Kaspasa tálmar og notkun þeirra | |
| EE200200414A (et) | Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis | |
| EE200100373A (et) | Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena | |
| EE200200251A (et) | Uued N-asabitsükloamiidi derivaadid ja nende kasutamine | |
| EE04566B1 (et) | Epotilooni derivaadid ja nende kasutamine meditsiinis | |
| NO20012245D0 (no) | Anthranilsyreamider og anvendelse derav som medikamenter | |
| EE200100568A (et) | 6-alkenüül-, 6-alkünüül- ja 6-epoksüepotilooni derivaadid, nende valmistamismeetod ja kasutamine farmatseutilistes preparaatides | |
| EE05067B1 (et) | Aminoproplfosfiinhapped ning nende kasutamine meditsiinis | |
| NO975513D0 (no) | 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel | |
| FI944600A7 (fi) | Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa | |
| EE05000B1 (et) | 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid | |
| EE200100416A (et) | Hargneva ahelaga aminohappe-sõltuvad aminotransferaasinhibiitorid ja nende kasutamine diabeetilise retinopaatia ravis | |
| EE9700288A (et) | Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis | |
| NO20012738D0 (no) | Terapeutiske produkter og anvendelse derav | |
| NO990300L (no) | <Alfa>-aminosyreamider, fremstilling og terapeutisk anvendelse derav | |
| EE9800333A (et) | Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
| EE9900135A (et) | N-(2-bensotiasolüül)-1-piperidiinetaanamiini derivaadid, nende valmistamine ja kasutamine raviks | |
| PT1140803E (pt) | (aminoiminometil)amino)alcanocarboxamidas e suas aplicacoes em terapia | |
| EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
| EE200300454A (et) | Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine | |
| FI954141L (fi) | Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa |